Skip to main content
. 2021 Oct 25;12(1):8679–8689. doi: 10.1080/21655979.2021.1991160

Figure 2.

Figure 2.

The EGFR and JAK/STAT pathways in glioma cells are inhibited by AZD3759. a. The expression levels of JAK1, p-JAK1, JAK2, p-JAK2, STAT3, p-STAT3, STAT5, p-STAT5, EGFR, p-EGFR, AKT, and p-AKT in C6 cells detected using western blot assay. b. The expression levels of JAK1, p-JAK1, JAK2, p-JAK2, STAT3, p-STAT3, STAT5, p-STAT5, EGFR, p-EGFR, AKT, and p-AKT in U87 cells detected using western blot assay (*p < 0.05 vs. control, **p < 0.01 vs. control, ##p < 0.01 vs. 4 μM AZD3759)